Physician profile
George Tung
NPI 1346275047
$6,667.59
in general payments reported to CMS, 2019-2025
21 companies · $436 in 2025
The $436 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,368 · 2020: $186 · 2021: $676 · 2022: $517 · 2023: $288 · 2024: $1,197 · 2025: $436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,922.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,921.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,293.67 | 2019-2025 | Clareon, Simbrinza |
| Bausch & Lomb Americas INC. | $676.89 | 2023-2025 | Envista Mx60 Iol, Envista Aspire Iol, Miebo |
| Glaukos Corporation | $468.09 | 2019-2025 | Idosetr |
| Johnson & Johnson Surgical Vision, INC. | $430.97 | 2019-2024 | Amo Phaco Needle, Tecnis Iol |
| Welch Allyn | $355.81 | 2019 | |
| Allergan, INC. | $199.48 | 2020-2022 | |
| Tarsus Pharmaceuticals, INC. | $166.77 | 2024-2025 | Xdemvy |
| Aerie Pharmaceuticals, INC. | $145.58 | 2021 | |
| Rxsight INC | $131.58 | 2024 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Genentech USA, INC. | $125.00 | 2023 | Vabysmo |
| Recordati_rare_diseases_inc. | $122.19 | 2024 | Cystadrops |
| Sight Sciences, INC. | $117.55 | 2022 | |
| Sun Pharmaceutical Industries INC. | $113.69 | 2020-2025 | |
| Abbvie INC. | $103.80 | 2022-2024 | Vuity, Alphagan P, Lumigan |
| Oyster Point Pharma, INC. | $62.13 | 2022-2025 | Tyrvaya |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $61.35 | 2019-2021 | |
| Harrow Eye, LLC | $24.64 | 2025 | Iheezo |
| Shire North American Group INC | $21.44 | 2019 | |
| Tearlab Corp | $18.57 | 2023 | Tearlab Osmolarity System |
| Kala Pharmaceuticals, INC. | $15.29 | 2021 | |
| Mallinckrodt Hospital Products INC. | $13.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Tung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.